The wound healing effect of leaf extracts of Ocimum gratissimum was investigated in adult male Wistar rats. Two groups of adult male Wistar rats, average body weight 170g, had a 2cm by 2cm square wound inflicted on the dorsolateral aspect of their trunk with Paniculus Carnosus removed. Experimental group had their wound dressed with methanolic leaf extracts of Ocimum gratissimum while control group had their wounds dressed with normal saline dressing. All animals had wound dressing done every five days; wound dimension measured and, wound morphometry assessed. Wound biopsy was done by random selection in each group on day 10 and the day of complete re-epithelisation. Routine paraffin wax processing was done, slides stained with haematoxylene and eosin for histological assessment of fibroblast count, neovascularisation and granulation tissue profile. The result revealed significant wound contraction (P<0.05) on day 10 in the experimental group (mean 73.40 +/- 3.30)cm2 compared with the control group (mean 53.50 +/- 4.32)cm2. Histology of the healed scar showed non-significant (P>0.05) decrease in the mean fibroblast count forthe experimental group (83.80 +/- 5.70) relative to fibroblast count of 90.20 +/- 17.90 in the control group. The mean blood vessel count was also non-significantly lowered (P>0.05) in the experimental group (9.20 +/- 1.20) relative to the control group (13.40 +/- 2.40). Granulation tissue histology on day 10 showed denser inflammatory infiltrate as reflected by increased cellularity in the control group relative to that of the experimental group which though appeared adequate was not as dense as the control group. Thus we suggest that the methanolic extracts of O. gratissimum could be a potential wound healing agent due to its ability to enhance wound contraction.
Download full-text PDF |
Source |
---|
Hum Vaccin Immunother
December 2025
Research and Development, Infectious Disease, Moderna, Inc., Cambridge, MA, USA.
Safety, immunogenicity, and effectiveness of an mRNA-1273 50-μg booster were evaluated in adolescents (12-17 years), with and without pre-booster SARS-CoV-2 infection. Participants who had received the 2-dose mRNA-1273 100-µg primary series in the TeenCOVE trial (NCT04649151) were offered the mRNA-1273 50-μg booster. Primary objectives included safety and inference of effectiveness by establishing noninferiority of neutralizing antibody (nAb) responses after the booster compared with the nAb post-primary series of mRNA-1273 among young adults in COVE (NCT04470427).
View Article and Find Full Text PDFJAMA Netw Open
January 2025
Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.
Importance: During buprenorphine treatment for opioid use disorder (OUD), risk factors for opioid relapse or treatment dropout include comorbid substance use disorder, anxiety, or residual opioid craving. There is a need for a well-powered trial to evaluate virtually delivered groups, including both mindfulness and evidence-based approaches, to address these comorbidities during buprenorphine treatment.
Objective: To compare the effects of the Mindful Recovery Opioid Use Disorder Care Continuum (M-ROCC) vs active control among adults receiving buprenorphine for OUD.
Transl Vis Sci Technol
January 2025
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China.
Purpose: This study investigates the association between visual function and retinal vasculature metrics, particularly perfusion capacity (PC), in eyes with idiopathic epiretinal membrane (iERM), using optical coherence tomography angiography (OCTA).
Methods: This retrospective study includes 30 eyes from 30 iERM patients who had surgery, with a three-month follow-up period. In addition, 28 eyes from 28 healthy individuals served as a control group.
Invest Ophthalmol Vis Sci
January 2025
Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
Purpose: This study aimed to evaluate early-phase safety of subretinal application of AAVanc80.CAG.USH1Ca1 (OT_USH_101) in wild-type (WT) pigs, examining the effects of a vehicle control, low dose, and high dose.
View Article and Find Full Text PDFJAMA Pediatr
January 2025
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Importance: Spontaneous reports have indicated that montelukast increases the risk of neuropsychiatric adverse events, and the US Food and Drug Administration added a boxed warning about these risks in 2020. However, the potential mechanism is not well understood, and the observational evidence is scarce, particularly in children.
Objective: To assess the potential association between the use of montelukast and the risk of neuropsychiatric adverse events in children and adolescents.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!